FRIDAY, June 28, 2024 -- In a clinical practice guideline issued by the American Society for Radiation Oncology and published online June 18 in...
Vous n'êtes pas connecté
- English
- Français
- عربي
- Español
- Deutsch
- Português
- русский язык
- Català
- Italiano
- Nederlands, Vlaams
- Norsk
- فارسی
- বাংলা
- اردو
- Azərbaycan dili
- Bahasa Indonesia
- Հայերեն
- Ελληνικά
- Bosanski jezik
- українська мова
- Íslenska
- Türkmen, Түркмен
- Türkçe
- Shqip
- Eesti keel
- magyar
- Қазақ тілі
- Kalaallisut ; kalaallit oqaasii
- Lietuvių kalba
- Latviešu valoda
- македонски јазик
- Монгол
- Bahasa Melayu ; بهاس ملايو
- ဗမာစာ
- Slovenščina
- тоҷикӣ ; toğikī ; تاجیکی
- ไทย
- O'zbek ; Ўзбек ; أۇزبېك
- Tiếng Việt
- ភាសាខ្មែរ
- རྫོང་ཁ
- Soomaaliga ; af Soomaali
Maroc - ONCOLOGYNEWS.COM.AU - A La Une - 25/Jun 13:46
ASTRO issues clinical guideline on radiation therapy for patients with HPV-related throat cancer
The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details best practices for using radiation therapy to treat patients who have oropharyngeal squamous cell carcinoma (OPSCC) caused by the human papillomavirus (HPV). Recommendations address radiation therapy as a stand-alone curative treatment or in combination with surgery and/or chemotherapy. The guideline also covers treatment [...]
Articles similaires
Cutaneous Squamous Cell Carcinoma Pipeline Insights 2024 | Clinical Trials, Latest Approvals, Treatment Outlook, Therapies, Companies | Incyte Corporation, Shanghai Henlius Biotech, Novartis, Rakuten
mountaintoday.in - 19/Jun 08:44
Cutaneous Squamous Cell Carcinoma Pipeline Insights 2024 “Cutaneous Squamous Cell Carcinoma Pipeline Insight, 2024” report by DelveInsight...
New global research aims to improve survival rates for pancreatic cancer patients
oncologynews.com.au - 26/Jun 15:44
A new study published in JAMA Network Open by an international cohort of researchers provides the latest data on the effectiveness of treating...
Squamous Cell Carcinoma Pipeline 2024 | FDA Approvals, Clinical Trials, Therapies, MOA, ROA | Hookipa Pharma, Zenith Epigenetics, HiFiBiO, Nanobiotix, GSK, AstraZeneca, VCN Biosciences, Moderna
mountaintoday.in - 18/Jun 18:56
DelveInsight’s, “Squamous Cell Carcinoma Pipeline Insight, 2024” report provides comprehensive insights about 75+...
Exploring Breast Cancer Stages: A Guide to Understanding the Classification System
popdiaries.com - 28/Jun 11:43
Breast cancer is a complex disease with varying degrees of severity and treatment approaches. Central to understanding and managing breast cancer is...
FDA Approves KEYTRUDA + Chemo for Primary Advanced, Recurrent Endometrial Carcinoma
drugs.com - 21/Jun 22:55
FRIDAY, June 21, 2024 -- The U.S. Food and Drug Administration has approved Keytruda (pembrolizumab) plus chemotherapy as treatment for adult...
ISTH Issues Clinical Practice Guideline for the Treatment of Hemophilia
drugs.com - 01/Jul 15:07
MONDAY, July 1, 2024 -- In a clinical practice guideline issued by the International Society on Thrombosis and Haemostasis and published online June...
Pre-Surgery Chemotherapy Benefits Pancreatic Cancer Patients
medindia.net - 21/Jun 09:50
Administering chemotherapy before surgery has shown benefits for select pancreatic cancer patients potentially improving treatment outcomes and...
Research paves way for new forms of immunotherapy to treat people with Merkel cell cancer
news.medical.net - 01/Jul 13:41
Scientists behind a new type of immunotherapy are demonstrating significant effects in laboratory experiments in cell samples from patients with the...
Assessing clinical benefit and safety in trial waivers for treatment-refractory cancers
news.medical.net - 27/Jun 16:06
Patients with treatment-refractory cancers who received eligibility and testing waivers to participate in a large basket/umbrella oncology trial had...
Les derniers communiqués
-
Aucun élément